Entera Bio (ENTX) vs Tectonic Therapeutic (TECX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Tectonic Therapeutic (TECX) has outperformed Entera Bio (ENTX) over the past year, gaining 52.3% versus a gain of 32.8%. Over five years, ENTX leads with a -44.5% price change compared with -67.4% for TECX. Tectonic Therapeutic is the larger company by market cap ($444.0 million vs $436.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ENTX | TECX |
|---|---|---|
| Share price | $2.51 | $22.71 |
| Market cap | $436.32M | $443.97M |
| 1-day change | -0.79% | +1.34% |
| YTD return | +29.38% | +8.87% |
| 1-year return | +32.80% | +52.31% |
| 5-year return | -44.47% | -67.37% |
| EPS (TTM) | $-0.36 | $-4.57 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.20 | $39.53 |
| 52-week low | $0.91 | $14.81 |
| Distance from 52-week high | -40.24% | -42.55% |
| Average volume | 1.81M | 220.06K |
| Shares outstanding | 173.83M | 19.55M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TECX has outperformed ENTX by 19.5 percentage points over the past year.
ENTX vs TECX FAQ
Which is bigger, Entera Bio or Tectonic Therapeutic?
Tectonic Therapeutic (TECX) is larger, with a market capitalization of $443.97M compared with $436.32M for Entera Bio (ENTX).
Which stock has performed better over the past year, ENTX or TECX?
TECX returned +52.31% over the past 12 months, compared with +32.80% for ENTX (price return, excluding dividends). Past performance does not predict future results.
Are Entera Bio and Tectonic Therapeutic in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.